Galectin Therapeutics Inc (NASDAQ:GALT)

2.59
Delayed Data
As of Jul 02
 -0.03 / -1.15%
Today’s Change
2.50
Today|||52-Week Range
16.55
-25.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization3.0K3.0K2.0K2.0K
 
 
 
 
 
 
Operating ExpensesGross Income-3.0K-3.0K-2.0K-2.0K
 
 
 
 
 
General Expenses3.4M3.5M3.7M4.8M
 
 
 
 
 
Research And Development1.6M2.0M2.1M3.1M
 
 
 
 
 
Total Operating Expenses3.4M3.5M3.7M4.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-3.5M-3.7M-4.8M
 
 
 
 
 
Pre-Tax Equity Earnings-67.0K-53.0K-10.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M-3.5M-3.7M-4.8M
 
 
 
 
 
Preferred Dividend-302.0K-278.0K-180.0K-248.0K
 
 
 
 
 
Net Income-3.4M-3.6M-3.8M-4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.0M22.1M22.3M23.1M
 
 
 
 
 
Shares To Calculate EPS Diluted22.0M22.1M22.3M23.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.17-$0.17-$0.22
 
 
 
 
 
EPS Diluted-$0.17-$0.17-$0.18-$0.22
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account